SERA
SERA PROGNOSTICS, INC.
SERA PROGNOSTICS, INC. (SERA) has 15 SEC Form 4 filings (22 transaction rows) in the rolling window, disclosed by 6 distinct insiders. Most recent filing: Jul 14, 2026.
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$91K
reported sales (SEC code S)
Unique Insiders
6
in the rolling window
Market Cap
$103.0M
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
| Chief Executive Officer | Sale | 6,990 | $14K | Jun 15 | SEC ↗ | |
Jackson BenjaminFirst filing | General Counsel | Sale | 2,179 | $4K | Jun 15 | SEC ↗ |
Anderson Dyaarl Lee Jr.First filing | Chief Commercial Officer | Sale | 4,739 | $10K | Jun 15 | SEC ↗ |
| Chief Financial Officer | Sale | 2,037 | $4K | Jun 15 | SEC ↗ | |
Inglis Tiffany Eul DavisFirst filing | Chief Medical Officer | Sale | 362 | $728 | Jun 15 | SEC ↗ |
Lindgardt ZhenyaFirst filing | Chief Executive Officer | Sale | 20,755 | $43K | Jun 10 | SEC ↗ |
Aerts AustinFirst filing | Chief Financial Officer | Sale | 5,440 | $11K | Jun 10 | SEC ↗ |
| Director | Sale | 1,560 | $3K | Jun 9 | SEC ↗ |
Related companies
SERA PROGNOSTICS, INC. is in the Healthcare sector.